330 related articles for article (PubMed ID: 11123381)
41. Oxidative detoxication of carcinogenic 2-nitroanisole by human, rat and rabbit cytochrome P450.
Dracínska H; Miksanová M; Svobodová M; Smrcek S; Frei E; Schmeiser HH; Stiborová M
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():9-13. PubMed ID: 17159769
[TBL] [Abstract][Full Text] [Related]
42. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.
Murray M; Butler AM
J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177
[TBL] [Abstract][Full Text] [Related]
43. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
44. Identification of multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine.
Myers MJ; Farrell DE; Howard KD; Kawalek JC
Drug Metab Dispos; 2001 Jun; 29(6):908-15. PubMed ID: 11353762
[TBL] [Abstract][Full Text] [Related]
45. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
46. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
47. Induction of rat hepatic cytochrome P450 enzymes by myristicin.
Jeong HG; Yun CH
Biochem Biophys Res Commun; 1995 Dec; 217(3):966-71. PubMed ID: 8554622
[TBL] [Abstract][Full Text] [Related]
48. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities.
Bhamre S; Anandatheerathavarada HK; Shankar SK; Boyd MR; Ravindranath V
Arch Biochem Biophys; 1993 Mar; 301(2):251-5. PubMed ID: 8460938
[TBL] [Abstract][Full Text] [Related]
49. Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers.
von Weymarn LB; Chun JA; Hollenberg PF
Carcinogenesis; 2006 Apr; 27(4):782-90. PubMed ID: 16364922
[TBL] [Abstract][Full Text] [Related]
50. Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.
Knickle LC; Webb CD; House AA; Bend JR
J Pharmacol Exp Ther; 1993 Nov; 267(2):758-64. PubMed ID: 8246152
[TBL] [Abstract][Full Text] [Related]
51. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins.
Cai Y; Baer-Dubowska W; Ashwood-Smith MJ; Ceska O; Tachibana S; DiGiovanni J
Chem Res Toxicol; 1996 Jun; 9(4):729-36. PubMed ID: 8831817
[TBL] [Abstract][Full Text] [Related]
52. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
Hollenberg PF; Kent UM; Bumpus NN
Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
[TBL] [Abstract][Full Text] [Related]
53. Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9.
Koenigs LL; Peter RM; Hunter AP; Haining RL; Rettie AE; Friedberg T; Pritchard MP; Shou M; Rushmore TH; Trager WF
Biochemistry; 1999 Feb; 38(8):2312-9. PubMed ID: 10029524
[TBL] [Abstract][Full Text] [Related]
54. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.
Chun YJ; Ryu SY; Jeong TC; Kim MY
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):389-93. PubMed ID: 11259321
[TBL] [Abstract][Full Text] [Related]
55. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
56. Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
Ding X; Spink DC; Bhama JK; Sheng JJ; Vaz AD; Coon MJ
Mol Pharmacol; 1996 Jun; 49(6):1113-21. PubMed ID: 8649351
[TBL] [Abstract][Full Text] [Related]
57. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver.
Arinç E; Bozcaarmutlu A
J Biochem Mol Toxicol; 2003; 17(3):169-76. PubMed ID: 12815613
[TBL] [Abstract][Full Text] [Related]
58. Modulation of carcinogen-metabolising cytochromes P450 in human liver by the chemopreventive phytochemical phenethyl isothiocyanate, a constituent of cruciferous vegetables.
Konsue N; Ioannides C
Toxicology; 2010 Feb; 268(3):184-90. PubMed ID: 20025923
[TBL] [Abstract][Full Text] [Related]
59. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
60. Mechanism-based inactivation of cytochrome P450 2B1 by 7-ethynylcoumarin: verification of apo-P450 adduction by electrospray ion trap mass spectrometry.
Regal KA; Schrag ML; Kent UM; Wienkers LC; Hollenberg PF
Chem Res Toxicol; 2000 Apr; 13(4):262-70. PubMed ID: 10775326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
